Decoy Therapeutics (DCOY) Total Current Liabilities (2014 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Total Current Liabilities of $4.5 million for Q1 2026, down 12.03% quarter-over-quarter from $5.2 million in Q4 2025.
Decoy Therapeutics (DCOY) Total Current Liabilities (2014 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Total Current Liabilities for 9 consecutive years, with $4.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities changed N/A year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (changed N/A YoY), while the FY2025 annual figure was $5.2 million, up 241.94% from the prior year.
- Total Current Liabilities slipped to $4.5 million in Q1 2026 per DCOY's latest filing, from $5.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $5.2 million in Q4 2025 and bottomed at $1.5 million in Q4 2024.
- Historically, Total Current Liabilities has averaged $3.7 million across 3 years, with a median of $4.5 million in 2026.
- On a YoY basis, Total Current Liabilities climbed as much as 241.94% in 2025 and fell as far as 241.94% in 2025.
- Decoy Therapeutics' Total Current Liabilities stood at $1.5 million in 2024, then surged by 241.94% to $5.2 million in 2025, then dropped by 12.03% to $4.5 million in 2026.
- Business Quant data shows DCOY's Total Current Liabilities at $4.5 million in Q1 2026, $5.2 million in Q4 2025, and $1.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 630.93 Mn |
| 10 | Decoy Therapeutics | 1.73 Mn | 1.73 Mn | - | 4.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.68 Mn |
| Mar 31, 2026 | 4.55 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Jun 30, 2019 | 1.04 Mn |
| Mar 31, 2019 | 911,118.00 |
| Dec 31, 2018 | 1.11 Mn |
| Sep 30, 2018 | 2.89 Mn |
| Jun 30, 2018 | 3.79 Mn |
| Mar 31, 2018 | 4.12 Mn |
| Dec 31, 2017 | 5.85 Mn |
| Sep 30, 2017 | 4.97 Mn |
| Jun 30, 2017 | 5.03 Mn |
| Mar 31, 2017 | 3.22 Mn |
| Dec 31, 2016 | 3.89 Mn |
| Sep 30, 2016 | 3.91 Mn |
| Jun 30, 2016 | 3.40 Mn |
| Mar 31, 2016 | 3.04 Mn |
| Dec 31, 2015 | 2.85 Mn |
| Sep 30, 2015 | 2.32 Mn |